title: CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
abstract: Osteonecrosis of the jaw is an uncommon but potentially serious complication of bisphosphonate therapy in multiple myeloma. Previous studies showed that the presence of one or two minor alleles of the cytochrome P450, subfamily 2C polypeptide 8 gene (CYP2C8) polymorphism rs1934951 was an independent prognostic marker associated with development of osteonecrosis of the jaw in multiple myeloma patients treated with bisphosphonates. The aim of this study was to validate the frequency of SNP rs193451 in 79 patients with multiple myeloma. In 9 (22%) patients developing osteonecrosis of the jaw, a heterozygous genotype was found, in contrast with those who did not develop osteonecrosis of the jaw (n=4, 11%) or healthy individuals (n=6, 13%). We found no differences in the cumulative risk of developing osteonecrosis of the jaw between patients homozygous and heterozygous for the major allele. We were unable to confirm a significant association between this polymorphism and the risk of developing osteonecrosis of the jaw.
authors.affiliation: Department of Hematology, Hospital Universitario La Fe, Valencia, Spain.
authors.forename: Esperanza
authors.initials: E
authors.lastname: Such
authors.forename: José
authors.initials: J
authors.lastname: Cervera
authors.forename: Evangelos
authors.initials: E
authors.lastname: Terpos
authors.forename: José V
authors.initials: JV
authors.lastname: Bagán
authors.forename: Amparo
authors.initials: A
authors.lastname: Avaria
authors.forename: Inés
authors.initials: I
authors.lastname: Gómez
authors.forename: María
authors.initials: M
authors.lastname: Margaix
authors.forename: Mariam
authors.initials: M
authors.lastname: Ibañez
authors.forename: Irene
authors.initials: I
authors.lastname: Luna
authors.forename: Lourdes
authors.initials: L
authors.lastname: Cordón
authors.forename: Mónica
authors.initials: M
authors.lastname: Roig
authors.forename: Miguel A
authors.initials: MA
authors.lastname: Sanz
authors.forename: Meletios A
authors.initials: MA
authors.lastname: Dimopoulos
authors.forename: Javier
authors.initials: J
authors.lastname: de la Rubia
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000483:Alleles; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D059266:Bisphosphonate-Associated Osteonecrosis of the Jaw / Q000150:complications / Q000235:genetics*; D065727:Cytochrome P-450 CYP2C8; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000150:complications* / Q000188:drug therapy / Q000235:genetics; D020641:Polymorphism, Single Nucleotide
chemical_list: D001189:Aryl Hydrocarbon Hydroxylases; C450259:CYP2C8 protein, human; D065727:Cytochrome P-450 CYP2C8